These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11039805)

  • 1. The safety and efficacy of intraoperative heparin in total hip arthroplasty.
    DiGiovanni CW; Restrepo A; González Della Valle AG; Sharrock NE; McCabe JP; Sculco TP; Pellicci PM; Salvati EA
    Clin Orthop Relat Res; 2000 Oct; (379):178-85. PubMed ID: 11039805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of D-dimer after total hip arthroplasty in patients with and without intraoperative heparin.
    Maezawa K; Nozawa M; Aritomi K; Kubota M; Shitoto K; Kurosawa H
    Arch Orthop Trauma Surg; 2008 Jan; 128(1):37-40. PubMed ID: 17522875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
    Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism is rare with a multimodal prophylaxis protocol after total hip arthroplasty.
    González Della Valle A; Serota A; Go G; Sorriaux G; Sculco TP; Sharrock NE; Salvati EA
    Clin Orthop Relat Res; 2006 Mar; 444():146-53. PubMed ID: 16446593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
    J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal prophylaxis of venous thrombosis.
    Salvati EA
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):4-11. PubMed ID: 12349894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of intraoperative heparin administered during total hip arthroplasty on the incidence of proximal deep vein thrombosis assessed by magnetic resonance venography.
    Westrich GH; Salvati EA; Sharrock N; Potter HG; Sánchez PM; Sculco TP
    J Arthroplasty; 2005 Jan; 20(1):42-50. PubMed ID: 15660059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy.
    Macdonald RL; Amidei C; Lin G; Munshi I; Baron J; Weir BK; Brown F; Erickson RK; Hekmatpanah J
    Neurosurgery; 1999 Aug; 45(2):245-51; discussion 251-2. PubMed ID: 10449068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of thrombosis in hip prosthesis implantation].
    Böttner F; Sculco TP; Sharrock NE; Westrich GH; Steinbeck J
    Orthopade; 2001 Nov; 30(11):890-6. PubMed ID: 11766633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
    Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials.
    Eikelboom JW; Quinlan DJ; Douketis JD
    Lancet; 2001 Jul; 358(9275):9-15. PubMed ID: 11454370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis against fat and bone-marrow embolism during total hip arthroplasty reduces the incidence of postoperative deep-vein thrombosis: a controlled, randomized clinical trial.
    Pitto RP; Hamer H; Fabiani R; Radespiel-Troeger M; Koessler M
    J Bone Joint Surg Am; 2002 Jan; 84(1):39-48. PubMed ID: 11792778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Benefit/risk ratio analysis from a possible anticoagulation of asymptomatic deep venous thrombosis in major orthopedic surgery].
    Barrellier MT; Samama CM
    J Mal Vasc; 2013 May; 38(3):178-84. PubMed ID: 23415379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
    Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
    Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.
    Colwell CW; Collis DK; Paulson R; McCutchen JW; Bigler GT; Lutz S; Hardwick ME
    J Bone Joint Surg Am; 1999 Jul; 81(7):932-40. PubMed ID: 10428124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement.
    Eriksson BI; Ekman S; Lindbratt S; Baur M; Bach D; Torholm C; Kälebo P; Close P
    J Bone Joint Surg Am; 1997 Mar; 79(3):326-33. PubMed ID: 9070519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.